SCHEMBL6508131

SCHEMBL6508131

N=C(N)Nc1nc(CCl)cs1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.61
KMT2A Q03164 1/20 0.61
MAPT P10636 2/20 0.40
KDM4E B2RXH2 2/20 0.40
GAA P10253 1/20 0.40
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
AOC3 Q16853 7/20 0.38
GFER P55789 2/20 0.37
MAOB P27338 1/20 0.36
ALDH1A1 P00352 3/20 0.36
PDE5A O76074 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
PDE1A P54750 1/20 0.36
PDE1B Q01064 1/20 0.36
PDE1C Q14123 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6512719 0.98 SMN1; SMN2 (0.59) SMN1; SMN2KMT2AMAPTKDM4EGAA
SCHEMBL10702053 0.84 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AKDM4EAOC3MAOB
SCHEMBL5879528 0.84 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AMAPTKDM4EGAA
SCHEMBL11248470 0.83 KMT2A (0.43) SMN1; SMN2KMT2ACDK5CDK5R1AOC3
SCHEMBL8008758 0.83 SMN1; SMN2 (0.41) SMN1; SMN2KMT2AMAPTKDM4EGAA
SCHEMBL8409815 0.83 SMN1; SMN2 (0.41) SMN1; SMN2KMT2AMAPTKDM4EGAA
Hydrochloric Acid SCHEMBL10703604 0.83 SMN1; SMN2 (0.41) SMN1; SMN2KMT2AKDM4EAOC3MAOB
SCHEMBL3478405 0.83 SMN1; SMN2 (0.41) SMN1; SMN2KMT2AMAPTKDM4EGAA
SCHEMBL9839087 0.83 SMN1; SMN2 (0.41) SMN1; SMN2KMT2AMAPTKDM4EGAA
Hydrochloric Acid SCHEMBL11249604 0.82 AOC3 (0.43) SMN1; SMN2KMT2AAOC3MAOBPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998040368-A1 SYNTHESIS OF THIAZOLE DERIVATIVES ALBEMARLE CORPORATION (US) 1998-09-17 WO claimed
US-5731442-A Synthesis of thiazole derivatives ALBEMARLE CORPORATION (US) 1998-03-24 US claimed
US-4347370-A HISTAMINE H-2 ANTAGONISTS, INHIBIT GASTRIC ACID SECRETION IMPERIAL CHEMICAL INDUSTRIES LTD. (GB) 1982-08-31 US claimed
CN-111825633-B Method for synthesizing 2-guanidyl thiazole compounds by one-pot method 西华大学 2023-11-17 CN disclosed
CN-219111359-U Stirring device for preparing famotidine preparation 江苏大同盟制药有限公司 2023-06-02 CN disclosed
CN-112006999-A Preparation method of famotidine preparation for injection 江苏大同盟制药有限公司 2020-12-01 CN disclosed
CN-111825633-A Method for synthesizing 2-guanidino thiazole compound by one-pot method 西华大学 2020-10-27 CN disclosed
WO-2005009986-A1 ONE-POT PREPARATION OF S-(GUANIDINO-4-YL-METHYL)-ISOTHIOUREA DIHYDROCHORIDE TALLURI VEERA VENKATA SATYANAR (IN) 2005-02-03 WO disclosed
US-5856501-A Synthesis of thiazole derivatives ALBEMARLE CORPORATION (US) 1999-01-05 US disclosed
WO-1998040368-A1 SYNTHESIS OF THIAZOLE DERIVATIVES ALBEMARLE CORPORATION (US) 1998-09-17 WO disclosed
US-5731442-A Synthesis of thiazole derivatives ALBEMARLE CORPORATION (US) 1998-03-24 US disclosed
US-4837316-A ANTIULCER AGENTS FUJIREBIO KABUSHIKI KAISHA (JP) 1989-06-06 US disclosed
EP-0284536-A1 A process for the preparation of 3-(2-guanidinothiazol-4-yl-methylthio)propionitrile CENTRO MARGA PARA LA INVESTIGACION S.A. (ES) 1988-09-28 EP disclosed
EP-0214823-A2 Alkylamide derivatives with H2-receptor antagonistic and cytoprotective action FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) 1987-03-18 EP disclosed
EP-0128736-B1 NOVEL 2-GUANIDINOTHIAZOLINE COMPOUNDS, THEIR PREPARATION, AND THEIR USE AS INTERMEDIATES YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1987-02-25 EP disclosed
US-4609737-A DIHALOACETONE AND AMIDINOTHIOUREA YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1986-09-02 US disclosed
US-4562261-A 2-Guanidinothiazoline compounds, and process for preparing them YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1985-12-31 US disclosed
EP-0128736-A1 Novel 2-guanidinothiazoline compounds, their preparation, and their use as intermediates YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1984-12-19 EP disclosed
EP-0057227-A1 IMINO-ALKYL AND AMINO-NITRILE CYANO-GUANIDINES Société de Recherches et de Synthèses Organiques SA (CH) 1982-08-11 EP disclosed
WO-1982000462-A1 IMINO-ALKYL AND AMINO-NITRILE CYANO-GUANIDINES RECH SYNTHESES ORGAN (CH) 1982-02-18 WO disclosed